Searchable abstracts of presentations at key conferences in endocrinology

ea0056gp2 | Acromegaly | ECE2018

Retinal vessel abnormalities in acromegaly

Fuchtbauer Laila , Olsson Daniel S , Norrman Lise-Lott , Bengtsson Bengt-AEke , Hellstrom Ann , Johannsson Gudmundur

Growth hormone (GH) and insulin like growth factor 1 (IGF-I) modulate and stimulate angiogenesis and endothelial function. Excess of GH, as in acromegaly, is associated with cardiovascular morbidity and mortality, which is reversible after normalization of IGF-I and GH. Diabetes mellitus (DM) is a common comorbidity in acromegaly, but the prevalence of diabetes retinopathy in patients with acromegaly is unknown. Also, the roles of GH and IGF-I in diabetes retinopathy are not f...

ea0099rc4.4 | Rapid Communications 4: Diabetes, Obesity, Metabolism and Nutrition | Part I | ECE2024

The beta-2-adrenoreceptor agonist fenoterol increases resting enery expenditure without activation of brown adipose tissue in humans

Fuchtbauer Laila , Senn Jael , Baumann Carole , Isenrich Anninja , Ehlen Laura , Fuh Marceline , Heeren Jorg , Betz Matthias

Brown adipose tissue (BAT) may directly dissipate energy into heat and is associlated with a metabolically favorable phenotype. Cold exposure activates BAT via the sympathetic nervous system and its transmitter norepinephrine. In rodents, the activation is facilitated by the β3-adrenoreceptor (β3-AR). In humans treatment with the β3-AR agonist mirabegon leads to a rather weak activation of BAT as compared to a cold stimulus. In vitro studies in cell lines from h...